Contrary to the opinion of Genya Dana and colleagues (Nature 483, 29; 2012) , the greater sophistication of modified microbes created by synthetic biology could make them less, not more, difficult to regulate, manage and monitor than their naturally occurring counterparts.
Several routes could lead to a hypothetical disaster scenario, in which artificially produced microorganisms spread unchecked in the environment (see go.nature.com/pncgxs). But we need to take into account that some of these paths would be favoured over others, and that ecological and other interactions might attenuate or amplify those different probabilities. Synthetic biology could then be used to engineer environmental safety into these organisms.
There is a danger that adverse public opinion could hinder the development of synthetic biology's potential. To prevent this, the media must refrain from hyping the benefits or risks of the technology. That will ensure that synthetic biology can be developed safely under a regulatory system that is based on the probability of occurrence of hazardous events, rather than on imagined possibilities. It is precisely because of the bitter contention in the United States over issues such as climate change, stem-cell research and evolution that we need a science media centre now more than ever.
Successful science media centres in other countries have demonstrated that they improve civic discourse, because journalists are better informed about the science behind the controversies. Policy-makers can make decisions based on the best available science, and citizens can make smarter personal life Media centre: more than public relations As chief executive of London's Science Media Centre, I find the prospect of a similar centre in the United States more exciting than Colin Macilwain seems to (Nature 483, 247; 2012). A network of science media centres (SMCs) is already flourishing in Japan, Canada, Australia, New Zealand and the United Kingdom, with Denmark soon to join the list. This model works and, given the calibre of the people involved in the US move, I am confident that they will be able to meet any challenges head-on.
The SMC model is popular with journalists because it bucks public-relations protocol. None of us promotes our brand name or any institutional message, we are just as happy to kill stories as to create them, and we embrace difficult and controversial issues. This special mix is likely to be as popular with US journalists as it is with those in the other countries.
Science journalists use quotes from SMCs and/or treat them as a source of background information. If US science journalists are less likely to use quotes, as Macilwain implies, then a US SMC would simply operate differently. However, a scarcity of specialist science journalists may force a US SMC to operate more like the Australian centre, which tends to work with general news reporters.
SMCs around the world will have to adapt to different cultures, in which attitudes to acceptable funding sources may vary. But what really matters is that SMCs should be independent of those funders, whether they be from industry, government, the media
Journals' role in ethical research
False evidence in medical research can endanger lives, so countermeasures must be stepped up -particularly in light of recent cases (see go.nature.com/9ivjnm).
Improving scrutiny and verifying source data would be prohibitively costly and time-consuming, even if it were legally feasible. Instead, journals should demand proof before publication that research has been approved by a recognized body, such as an independent ethics committee or institutional review board, so that fraudulent claims can be identified (see, for example, Nature 477, 384; 2011). This approval is legally required in most countries and has now become an international standard (see go.nature.com/ krrr6g), so is easy to obtain.
Authors and their institutions should inform the journal promptly should their results be later invalidated, and permit inspection or auditing of reports if necessary (S. Kleinert and R. Horton Lancet 372, 789-790; 2008 
